Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,138 INR | -0.59% | +7.44% | -0.96% |
Apr. 16 | Alkem Laboratories Limited Receives A Demand Order Levying A Penalty of INR 35,099 State Tax Officer, Ghatak | CI |
Mar. 28 | Alkem Laboratories Forms Subsidiary for Medical Devices Business | MT |
Sales 2024 * | 129B 1.55B | Sales 2025 * | 142B 1.7B | Capitalization | 617B 7.4B |
---|---|---|---|---|---|
Net income 2024 * | 18.67B 224M | Net income 2025 * | 21.7B 260M | EV / Sales 2024 * | 4.63 x |
Net cash position 2024 * | 20.12B 241M | Net cash position 2025 * | 27.86B 334M | EV / Sales 2025 * | 4.15 x |
P/E ratio 2024 * |
33.7
x | P/E ratio 2025 * |
28.6
x | Employees | 16,871 |
Yield 2024 * |
0.84% | Yield 2025 * |
0.94% | Free-Float | 36.2% |
Latest transcript on Alkem Laboratories Limited
1 day | -0.50% | ||
1 week | +7.44% | ||
Current month | +6.44% | ||
1 month | +5.36% | ||
3 months | -3.45% | ||
6 months | +20.10% | ||
Current year | -0.96% |
Managers | Title | Age | Since |
---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | - | 23-09-21 |
Nitin Agrawal
DFI | Director of Finance/CFO | - | Jan. 31 |
Manish Narang
CMP | Compliance Officer | 54 | 06-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | - | |
Director/Board Member | 78 | 15-03-15 | |
Chief Executive Officer | 84 | 73-08-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 5,138 | -0.59% | 102 |
24-05-08 | 5,168 | +1.04% | 7,333 |
24-05-07 | 5,115 | -0.64% | 3,133 |
24-05-06 | 5,148 | +5.08% | 6,482 |
24-05-03 | 4,899 | +2.36% | 1,450 |
Delayed Quote Bombay S.E., May 08, 2024 at 11:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.95% | 700B | |
+26.51% | 569B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B |
- Stock Market
- Equities
- ALKEM Stock
- ALKEM Stock